PMV Pharmaceuticals, Inc.

NASDAQ:PMVP

1.75 (USD) • At close November 11, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Operating Activities:
Net Income -19.226-1.213-15.27-15.756-16.64-17.436-19.128-19.345-18.229-17.31-18.433-18.359-15.011-12.874-11.602-10.454-8.765-7.966-7.255-7.047-6.176-6.057-6.057
Depreciation & Amortization 0.3710.3720.3620.3590.3580.3690.1710.0750.0740.0820.0840.0770.080.0710.0790.0610.0750.0880.0940.0950.1070.0930.093
Deferred Income Tax 0002.799-1.842-0.957000000.0910.1270000.0050.060.08700.00100
Stock Based Compensation 2.2242.7672.612.9663.3243.1532.9323.0522.4482.5182.1771.7671.7961.150.6270.5840.670.3830.2960.2390.2390.2150.215
Change In Working Capital 4.22-2.046-2.1742.308-0.7642.0681.8151.341-0.8960.95-1.9634.0680.2971.933-2.175-0.5020.5210.501-1.3651.5380.1160.0650.065
Accounts Receivables 00000000000000000000000
Change In Inventory 00000000000000000000000
Change In Accounts Payables -2.473.68-2.3841.553-1.8112.013-1.52-1.2562.209-1.5810.2390.576-1.1471.117-0.3551.595-1.620.05-1.2552.083-0.42100
Other Working Capital 5.516-5.7260.210.7551.0470.0551.522.597-3.1052.531-2.2023.4921.4440.816-1.82-2.0972.1410.451-0.11-0.5450.5370.0650.065
Other Non Cash Items -4.428-1.6474.006-4.761-0.095-0.098-0.802-0.447-0.1560.0810.1370.3280.3130.4790.167-0.0010.1010.0380.0050.048-0.0140.0780.078
Operating Cash Flow -16.839-1.598-16.184-12.085-15.659-12.901-15.012-15.324-16.759-13.679-17.998-12.028-12.398-9.241-12.904-10.312-7.393-6.896-8.138-5.127-5.727-5.606-5.606
Investing Activities:
Investments In Property Plant And Equipment -0.001-0.004-0.594-0.197-0.044-0.565-0.156-1.638-2.05-3.5-0.796-0.262-0.501-0.466-0.12-0.057-0.040-0.0510-0.008-0.051-0.051
Acquisitions Net 000-0.0470.0340.063-0.05-0.025-0.0320.01202.7400000000000
Purchases Of Investments -39.399-40.885-30.489-33.392-57.595-106.05-23.502-34.687-45.289-55.518-93.705-21.678-49.943-45.447-139.777-14.6180.1060.21-14.828-25.122-7.59500
Sales Maturities Of Investments 56.4943.21257.24931.0012442.65273.30359.54876.85243.73955.67629.49949.75135.360-7.9717.97126.1058.4956.5686.61400
Other Investing Activites 0.0292.32726.760.047-0.034-0.0630.050.0250.032-0.012-38.029-2.74-0.192-10.087-139.77722.5898.07726.315-6.333-18.554-0.98111.43811.438
Investing Cash Flow 17.1192.32326.166-2.588-33.639-63.96349.64523.22329.513-15.279-38.8257.559-0.693-10.553-139.897-0.0578.03726.315-6.384-18.554-0.98911.38711.387
Financing Activities:
Debt Repayment 00000000000000000000000
Common Stock Issued 00.14100.28833.0952.1310.0120.9580.0060.2760.1282.0220.3091.2560.162-1.3650000000
Common Stock Repurchased 00000000000000000000000
Dividends Paid 00000000000000000000000
Other Financing Activities -0.1410.14100.4050.0510.0020-0.4100.2760.128-1.7270.3091.2560.162-1.359294.455-0.124061.70500.050.05
Financing Cash Flow 00.14100.28833.1462.1310.0120.5480.0060.2760.1280.2950.3091.2560.162-1.359294.455-0.124061.70500.050.05
Other Information:
Effect Of Forex Changes On Cash 0.0040.006-0.0340.0340000000000000000000
Net Change In Cash 0.2840.8729.948-14.351-16.152-74.73334.6458.44712.76-28.682-56.695-4.174-12.782-18.538-152.639-11.728295.09919.295-14.52238.024-6.7165.8325.832
Cash At End Of Period 49.63249.34848.47638.52852.87969.031143.764109.119100.67287.912116.594173.289177.463190.245208.783361.422373.1578.05158.75673.27835.25441.975.832